TypeName: Business Offer
Offer Date:2018/09/25
Country: United States
Summary: Catechol-O-methyltransferase (COMT; EC 2.1.1.6) is one of several enzymes that degrade catecholamines such as dopamine, epinephrine, and norepinephrine. In Humans, catechol-O-methyltransferase protein is encoded by the COMT gene. As the regulation of catecholamines is impaired in a number of medical conditions, several pharmaceutical drugs target COMT to alter its activity and therefore the availability of catecholamines. COMT was first discovered by the biochemist Julius Axelrod in 1957.
Description: https://www.creative-enzymes.com/similar/COMT_149.html
OfferId: 2114
Name:Iva Colter
Telphone: